NCT05561634View on ClinicalTrials.gov

Radiotherapy by Sonic Hedgehog Pathway Inhibitors in Basal Cell Carcinoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

June 20, 2023

Primary Completion Date

June 20, 2029

Study Completion Date

June 20, 2029

Conditions
Basal Cell CarcinomaRadiotherapy; Complications
Interventions
RADIATION

Radiotherapy

Irradiation of the tumoral bed.

OTHER

Observation

Patients will be followed up in consultation every 3 months.

DRUG

Vismodegib

Sonic Hedgehog inhibitors (SHHi) = Vismodegib et Sonidegib,

Trial Locations (1)

Unknown

RECRUITING

CHU Lille, Lille

All Listed Sponsors
collaborator

Sun Pharmaceutical Industries Limited

INDUSTRY

lead

University Hospital, Lille

OTHER